Based on these findings and the fact that LDL pheresis can be used in some cases of FSGS, CLCF-1 has been proposed as a potential circulating factor in the pathogenesis of FSGS (60). The gene discussed is CLCF1; the disease is focal segmental glomerulosclerosis.